Editorial Notice · Plain-Text Status No Public Inbox Yet

Contact & public inbox status

Melanotans does not have a public inbox yet. This page carries no contact form, email address, telephone line, or mailing address.

Public inbox status

Melanotans currently operates as a static educational archive with no public inbox yet. Rather than publish an unmonitored form or placeholder address, we state that plainly here.

What this publication cannot handle

Because Melanotans is an independent educational guide—not a clinic, pharmacy, laboratory, manufacturer, or seller—it cannot provide individual medical evaluations, discuss personal dosing or side effects, recommend healthcare providers or pharmacies, test or verify products purchased online, or direct readers to any peptide supplier.

Where to check official records or report suspected reactions

Readers looking to inspect official regulatory documents or locate their national adverse-event reporting system can consult the agency sources cited directly in Dispatch 08 (Regulatory Records From Six Jurisdictions) and listed in full on the Primary Source Ledger—including U.S. FDA prescribing records and compounding notices, European Medicines Agency assessment reports, the UK MHRA Yellow Card Scheme cited in FOI 24/274, Australia's TGA consumer safety portal, and New Zealand's Medsafe advisories.